{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:29:42Z","timestamp":1791674982214,"version":"4.3.4"},"reference-count":54,"publisher":"IMR Press","issue":"1","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Integr. Neurosci."],"abstract":"<jats:p>Background: Biomarker detection strategies have, in recent years, been moving towards nucleic acid-based detection systems in the form of aptamers, short oligonucleotide sequences which have shown promise in pre-clinical and research settings. One such aptamer is M5-15, a DNA aptamer raised against human alpha synuclein (\u03b1-syn) the causative agent in Lewy body and Parkinson\u2019s disease (PD) associated dementia. While this aptamer has shown promise, in silico methodologies have demonstrated a capacity to produce aptamers that have higher affinities for their targets than in vitro generated sequences. Methods: A Python script random generated library of DNA sequences were screened based on their thermodynamic stability with the use of DINAMelt server-QuickFold web server. The selected sequences were examined with MFold in order to generate secondary structure data that were used to produce 3D data with the use of RNA composer software. Further on, the structure was corrected and RNA was replaced with DNA and the virtual screening for \u03b1-syn aptamer took place with a series of molecular docking experiments with the use of CSD-Discovery-GOLD software. Results: Herein we propose an alternative in silico generated aptamer we call TMG-79 which demonstrates greater affinity for the target compared to M5-15 (M5-15 = \u201315.9 kcal\/mol, TMG-79 = \u201317.77 kcal\/mol) as well as better ChemPLP fitness scoring between the top poses (M5-15 = 32.33, TMG-79 = 53.32). Structural analysis suggests that while there are similarities, the greater potential flexibility of TMG-79 could be promoting greater affinity for the \u03b1-syn compared to M5-15. Conclusions: In silico methods of aptamer generation has the potential to revolutionise the field of aptamer design. We feel that further development of TMG-79 and validation in vitro will make it a viable candidate for diagnostic and research use in the future.<\/jats:p>","DOI":"10.31083\/j.jin2101005","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T11:28:26Z","timestamp":1643455706000},"source":"Crossref","is-referenced-by-count":13,"title":["Development and validation of anti-human Alpha synuclein DNA aptamer using computer modelling techniques\u2014an in silico study"],"prefix":"10.31083","volume":"21","author":[{"given":"Marcus","family":"Rock","sequence":"first","affiliation":[{"name":"Human Sciences Research Centre, University of Derby, DE22 1GB Derby, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios D.","family":"Zouganelis","sequence":"first","affiliation":[{"name":"Human Sciences Research Centre, University of Derby, DE22 1GB Derby, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Flavia Belchior","family":"de Andrade","sequence":"first","affiliation":[{"name":"Human Sciences Research Centre, University of Derby, DE22 1GB Derby, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha J.","family":"Drake","sequence":"first","affiliation":[{"name":"Human Sciences Research Centre, University of Derby, DE22 1GB Derby, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Alexiou","sequence":"first","affiliation":[{"name":"Department of Science & Engineering, Novel Global Community Educational Foundation, 2770 Hebersham, Australia"},{"name":"AFNP Med Austria, 1010 Wien, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Albrakati","sequence":"first","affiliation":[{"name":"Department of Human Anatomy, College of Medicine, Taif University, P.O. BOX 11099, 21944 Taif, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"first","affiliation":[{"name":"Department of Pharmacology & Therapeutics, Faculty of Veterinary Medicine, Damanhour University, 22511 Damanhour, AlBeheira, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Arron","family":"Illingworth","sequence":"first","affiliation":[{"name":"Human Sciences Research Centre, University of Derby, DE22 1GB Derby, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Liu JKH. The history of monoclonal antibody development - Progress, remaining challenges and future innovations. Annals of Medicine and Surgery. 2015; 3: 113\u2013116.","DOI":"10.1016\/j.amsu.2014.09.001"},{"key":"ref2","unstructured":"Shoae M, Khorashadizadeh M, Derakhshani A, Safarnejad MR, Safarpour H. An overview of the current status of engineered therapeutic monoclonal antibodies. International Pharmacy Acta. 2019; 2: e9."},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Little M, Kipriyanov SM, Le Gall F, Moldenhauer G. Of mice and men: hybridoma and recombinant antibodies. Immunology Today. 2000; 21: 364\u2013370.","DOI":"10.1016\/S0167-5699(00)01668-6"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Zhou H, Pisitkun T, Aponte A, Yuen PST, Hoffert JD, Yasuda H, et al. Exosomal Fetuin-a identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. Kidney International. 2007; 70: 1847\u20131857.","DOI":"10.1038\/sj.ki.5001874"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Desplat-J\u00e9go S, Johanet C, Escande A, Goetz J, Fabien N, Olsson N, et al. Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study. World Journal of Gastroenterology. 2007; 13: 2312\u20132318.","DOI":"10.3748\/wjg.v13.i16.2312"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Klutz S, Holtmann L, Lobedann M, Schembecker G. Cost evaluation of antibody production processes in different operation modes. Chemical Engineering Science. 2016; 141: 63\u201374.","DOI":"10.1016\/j.ces.2015.10.029"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Zhang P, Woen S, Wang T, Liau B, Zhao S, Chen C, et al. Challenges of glycosylation analysis and control: an integrated approach to producing optimal and consistent therapeutic drugs. Drug Discovery Today. 2018; 21: 740\u2013765.","DOI":"10.1016\/j.drudis.2016.01.006"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Mayer G. The chemical biology of aptamers. Angewandte Chemie. 2009; 48: 2672\u20132689.","DOI":"10.1002\/anie.200804643"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Blind M, Blank M. Aptamer Selection Technology and Recent Advances. Molecular Therapy-Nucleic Acids. 2019; 4: e223.","DOI":"10.1038\/mtna.2014.74"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature. 1990; 346: 818\u2013822.","DOI":"10.1038\/346818a0"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 1990; 249: 505\u2013510.","DOI":"10.1126\/science.2200121"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Robertson DL, Joyce GF. Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA. Nature. 1990; 344: 467\u2013468.","DOI":"10.1038\/344467a0"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Acquah C, Danquah MK, Yon JLS, Sidhu A, Ongkudon CM. A review on immobilised aptamers for high throughput biomolecular detection and screening. Analytica Chimica Acta. 2015; 888: 10\u201318.","DOI":"10.1016\/j.aca.2015.05.050"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Gelinas AD, Davies DR, Janjic N. Embracing proteins: structural themes in aptamer-protein complexes. Current Opinion in Structural Biology. 2016; 36: 122\u2013132.","DOI":"10.1016\/j.sbi.2016.01.009"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Kr\u00fcger A, Zimbres FM, Kronenberger T, Wrenger C. Molecular Modeling Applied to Nucleic Acid-Based Molecule Development. Biomolecules. 2018; 8: 83.","DOI":"10.3390\/biom8030083"},{"key":"ref16","unstructured":"Team HeidlburgTeam. 2021. Available at: http:\/\/2015.igem.org\/Team:Heidelberg\/software\/maws (Accessed: 29 June 2021)."},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Sabri MZ, Abdul Hamid AA, Sayed Hitam SM, Abdul Rahim MZ. In Silico Screening of Aptamers Configuration against Hepatitis B Surface Antigen. Advances in Bioinformatics. 2020; 2019: 6912914.","DOI":"10.1155\/2019\/6912914"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Tombelli S, Minunni M, Mascini M. Analytical applications of aptamers. Biosensors & Bioelectronics. 2005; 20: 2424\u20132434.","DOI":"10.1016\/j.bios.2004.11.006"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Lecocq S, Spinella K, Dubois B, Lista S, Hampel H, Penner G. Aptamers as biomarkers for neurological disorders. Proof of concept in transgenic mice. PLoS ONE. 2018; 13: e0190212.","DOI":"10.1371\/journal.pone.0190212"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Stefanis L. \u0391-Synuclein in Parkinson\u2019s disease. Cold Spring Harbor Perspectives in Medicine. 2013; 2: a009399.","DOI":"10.1101\/cshperspect.a009399"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Crews L, Tsigelny I, Hashimoto M, Masliah E. Role of Synucleins in Alzheimer\u2019s Disease. Neurotoxicity Research. 2009; 16: 306\u2013317.","DOI":"10.1007\/s12640-009-9073-6"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Zheng Y, Qu J, Xue F, Zheng Y, Yang B, Chang Y, et al. Novel DNA Aptamers for Parkinson\u2019s Disease Treatment Inhibit \u03b1-Synuclein Aggregation and Facilitate its Degradation. Molecular Therapy-Nucleic Acids. 2018; 11: 228\u2013242.","DOI":"10.1016\/j.omtn.2018.02.011"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Twohig D, Nielsen HM. \u03b1-synuclein in the pathophysiology Warner of Alzheimer\u2019s disease. Molecular Neurodegeneration. 2019; 14: 1\u201319.","DOI":"10.1186\/s13024-019-0320-x"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Tsukakoshi K, Harada R, Sode K, Ikebukuro K. Screening of DNA aptamer which binds to \u03b1-synuclein. Biotechnology Letters. 2010; 32: 643\u2013648.","DOI":"10.1007\/s10529-010-0200-5"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Ren X, Zhao Y, Xue F, Zheng Y, Huang H, Wang W, et al. Exosomal DNA Aptamer Targeting \u03b1-Synuclein Aggregates Reduced Neuropathological Deficits in a Mouse Parkinson\u2019s Disease Model. Molecular Therapy. Nucleic Acids. 2020; 17: 726\u2013740.","DOI":"10.1016\/j.omtn.2019.07.008"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Zulkeflee Sabri M, Azzar Abdul Hamid A, Mariam Sayed Hitam S, Zulkhairi Abdul Rahim M. In-Silico Selection of Aptamer: a Review on the Revolutionary Approach to Understand the Aptamer Design and Interaction through Computational Chemistry. Materials Today: Proceedings. 2019; 19: 1572\u20131581.","DOI":"10.1016\/j.matpr.2019.11.185"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Navien TN, Thevendran R, Hamdani HY, Tang T, Citartan M. In silico molecular docking in DNA aptamer development. Biochimie. 2021; 180: 54\u201367.","DOI":"10.1016\/j.biochi.2020.10.005"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Hamada M. In silico approaches to RNA aptamer design. Biochimie. 2018; 145: 8\u201314.","DOI":"10.1016\/j.biochi.2017.10.005"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Nabuurs SB, Wagener M, de Vlieg J. A flexible approach to induced fit docking. Journal of Medicinal Chemistry. 2008; 50: 6507\u20136518.","DOI":"10.1021\/jm070593p"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Wang T, Chen C, Larcher LM, Barrero RA, Veedu RN. Three decades of nucleic acid aptamer technologies: Lessons learned, progress and opportunities on aptamer development. Biotechnology Advances. 2019; 37: 28\u201350.","DOI":"10.1016\/j.biotechadv.2018.11.001"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Markham NR, Zuker M. DINAMelt web server for nucleic acid melting prediction. Nucleic Acids Research. 2005; 33: 577\u2013581.","DOI":"10.1093\/nar\/gki591"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Research. 2003; 31: 3406\u20133415.","DOI":"10.1093\/nar\/gkg595"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Popenda M, Szachniuk M, Antczak M, Purzycka KJ, Lukasiak P, Bartol N, et al. Automated 3D structure composition for large RNAs. Nucleic Acids Research. 2012; 40: e112.","DOI":"10.1093\/nar\/gks339"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Macrae CF, Bruno IJ, Chisholm JA, Edgington PR, McCabe P, Pidcock E, et al. Mercury CSD 2.0\u2013 new features for the visualization and investigation of crystal structures. Journal of Applied Crystallography. 2008; 41: 466\u2013470.","DOI":"10.1107\/S0021889807067908"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Schiffrin B, Radford SE, Brockwell DJ, Calabrese AN. PyXlinkViewer: A flexible tool for visualization of protein chemical crosslinking data within the PyMOL molecular graphics system. Protein Science. 2020; 29:1851\u20131857.","DOI":"10.1002\/pro.3902"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Liang X, Kuhn H, Frank-Kamenetskii MD. Monitoring single-stranded DNA secondary structure formation by determining the topological state of DNA catenanes. Biophysical Journal. 2006; 90: 2877\u20132889.","DOI":"10.1529\/biophysj.105.074104"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Ulmer TS, Bax A, Cole NB, Nussbaum RL. Structure and Dynamics of Micelle-bound Human \u03b1-Synuclein. Journal of Biological Chemistry. 2005; 280: 9595\u20139603.","DOI":"10.1074\/jbc.M411805200"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Warner KD, Chen MC, Song W, Strack RL, Thorn A, Jaffrey SR, et al. Structural basis for activity of highly efficient RNA mimics of green fluorescent protein. Nature Structural & Molecular Biology. 2014; 21: 658\u2013663.","DOI":"10.1038\/nsmb.2865"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Meng X, Zhang H, Mezei M, Cui M. Molecular docking: a powerful approach for structure-based drug discovery. Current Computer-Aided Drug Design. 2011; 7: 146\u2013157.","DOI":"10.2174\/157340911795677602"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Nguyen ED, Norn C, Frimurer TM, Meiler J. Assessment and challenges of ligand docking into comparative models of G-protein coupled receptors. PLoS ONE. 2014; 8: e67302.","DOI":"10.1371\/journal.pone.0067302"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Luscombe NM, Laskowski RA, Thornton JM. Amino acid-base interactions: a three-dimensional analysis of protein-DNA interactions at an atomic level. Nucleic Acids Research. 2001; 29: 2860\u20132874.","DOI":"10.1093\/nar\/29.13.2860"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Faucher F, Wallace SS, Doubli\u00e9 S. The C-terminal lysine of Ogg2 DNA glycosylases is a major molecular determinant for guanine\/8-oxoguanine distinction. Journal of Molecular Biology. 2010; 397: 46\u201356.","DOI":"10.1016\/j.jmb.2010.01.024"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Jeong E, Kim H, Lee S, Han K. Discovering the interaction propensities of amino acids and nucleotides from protein-RNA complexes. Molecules and Cells. 2004; 16: 161\u2013167.","DOI":"10.1016\/S1016-8478(23)13783-6"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Sathyapriya R, Vishveshwara S. Interaction of DNA with clusters of amino acids in proteins. Nucleic Acids Research. 2004; 32: 4109\u20134118.","DOI":"10.1093\/nar\/gkh733"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Rooman M, Li\u00e9vin J, Buisine E, Wintjens R. Cation\u2013\u03c0\/H-bond Stair Motifs at Protein\u2013DNA Interfaces. Journal of Molecular Biology. 2002; 319: 67\u201376.","DOI":"10.1016\/S0022-2836(02)00263-2"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Sanford JR, Ellis J, C\u00e1ceres JF. Multiple roles of arginine\/serine-rich splicing factors in RNA processing. Biochemical Society Transactions. 2005; 33: 443\u2013446.","DOI":"10.1042\/BST0330443"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Kirchler T, Briesemeister S, Singer M, Sch\u00fctze K, Keinath M, Kohlbacher O, et al. The role of phosphorylatable serine residues in the DNA-binding domain of Arabidopsis bZIP transcription factors. European Journal of Cell Biology. 2010; 89: 175\u2013183.","DOI":"10.1016\/j.ejcb.2009.11.023"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Spinelli KJ, Taylor JK, Osterberg VR, Churchill MJ, Pollock E, Moore C, et al. Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson\u2019s disease. Journal of Neuroscience. 2014; 34: 2037\u20132050.","DOI":"10.1523\/JNEUROSCI.2581-13.2014"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Surguchev AA, Surguchov A. Synucleins and Gene Expression: Ramblers in a Crowd or Cops Regulating Traffic? Frontiers in Molecular Neuroscience. 2019; 10: 224.","DOI":"10.3389\/fnmol.2017.00224"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Zanzoni A, Marchese D, Agostini F, Bolognesi B, Cirillo D, Botta-Orfila M, et al. Principles of self-organization in biological pathways: a hypothesis on the autogenous association of alpha-synuclein. Nucleic Acids Research. 2013; 41: 9987\u20139998.","DOI":"10.1093\/nar\/gkt794"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Musafia B, Oren-Banaroya R, Noiman S. Designing anti-influenza aptamers: novel quantitative structure activity relationship approach gives insights into aptamer-virus interaction. PLoS ONE. 2015; 9: e97696.","DOI":"10.1371\/journal.pone.0097696"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Autiero I, Ruvo M, Improta R, Vitagliano L. The intrinsic flexibility of the aptamer targeting the ribosomal protein S8 is a key factor for the molecular recognition. Biochimica Et Biophysica Acta. General Subjects. 2018; 1862: 1006\u20131016.","DOI":"10.1016\/j.bbagen.2018.01.014"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Adachi H, Ishiguro A, Hamada M, Sakota E, Asai K, Nakamura Y. Antagonistic RNA aptamer specific to a heterodimeric form of human interleukin-17a\/F. Biochimie. 2011; 93: 1081\u20131088.","DOI":"10.1016\/j.biochi.2011.04.003"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Troisi R, Napolitano V, Spiridonova V, Russo Krauss I, Sica F. Several structural motifs cooperate in determining the highly effective anti-thrombin activity of NU172 aptamer. Nucleic Acids Research. 2018; 46: 12177\u201312185.","DOI":"10.1093\/nar\/gky990"}],"container-title":["Journal of Integrative Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/JIN\/21\/1\/10.31083\/j.jin2101005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T15:23:23Z","timestamp":1732721003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/JIN\/21\/1\/10.31083\/j.jin2101005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"alternative-id":["S0219-6352(22)00265-0"],"URL":"https:\/\/doi.org\/10.31083\/j.jin2101005","relation":{},"ISSN":["0219-6352","1757-448X"],"issn-type":[{"value":"0219-6352","type":"print"},{"value":"1757-448X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]},"article-number":"5"}}